Tonghua Golden-Horse Pharmaceutical Industry CoLtd Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Hongjun Zhan
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.4yrs |
| CEO ownership | n/a |
| Management average tenure | 18.5yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's (SZSE:000766) Popularity With Investors Is Under Threat From Overpricing
Aug 20
Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Seems To Use Debt Quite Sensibly
Jun 03Should You Be Adding Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) To Your Watchlist Today?
May 12Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Mar 06CEO
Hongjun Zhan (54 yo)
4.4yrs
Tenure
CN¥960,000
Compensation
Mr. Hongjun Zhan is General Manager of Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd from August 19, 2020. He served as Non-Independent Director of Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| General Manager | 4.4yrs | CN¥960.00k | no data | |
| Deputy GM & CFO | 18.5yrs | CN¥600.00k | no data | |
| Deputy GM & Non-Independent Director | no data | CN¥600.00k | no data | |
| Secretary & Deputy GM | 22.6yrs | CN¥480.00k | no data |
18.5yrs
Average Tenure
53.5yo
Average Age
Experienced Management: 000766's management team is seasoned and experienced (18.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Deputy GM & Non-Independent Director | 1.5yrs | CN¥600.00k | no data | |
| Chairman of the Supervisory Board | 13.6yrs | no data | no data | |
| Independent Director | 6.7yrs | CN¥50.40k | no data | |
| Chairman | 5.3yrs | CN¥900.00k | no data | |
| Non-Independent Director | 5.3yrs | CN¥420.00k | no data | |
| Non-Independent Director | 4.8yrs | no data | 0.019% CN¥ 2.7m | |
| Non-Independent Director | 4.8yrs | no data | no data | |
| Independent Director | 4.8yrs | CN¥50.40k | no data | |
| Supervisor | 4.8yrs | no data | no data | |
| Supervisor | 4.8yrs | no data | no data | |
| Non-Independent Director | 1.5yrs | no data | no data | |
| Independent Director | 1.5yrs | no data | no data |
4.8yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 000766's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/04 04:45 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Min Qiu | China Merchants Securities Co. Ltd. |